Von willebrand disease in women

Obstetrics and Gynecology

Volumn 114, Issue 6, 2009, Pages 1439-1443

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN ACETATE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ANAMNESIS; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BLOOD CELL COUNT; CLINICAL ASSESSMENT; CLINICAL FEATURE; DRUG MECHANISM; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; NOTE; OVARY CYST; PARTIAL THROMBOPLASTIN TIME; PATIENT REFERRAL; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; UNITED STATES; VON WILLEBRAND DISEASE; ARTICLE; BLOOD CLOTTING TEST;

BLOOD COAGULATION TESTS; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; MENORRHAGIA; REFERRAL AND CONSULTATION; VON WILLEBRAND DISEASES;

EID: 73449138383     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181c6f975     Document Type: Note

References (33)

1. National Women's Health Information Center. Bleeding disorders: frequently asked questions. Washington, DC: NWHIC; 2009. Available at: http://www.womenshealth. gov/FAQ/bleeding-disorders.cfm. Retrieved August 14, 2009.
2. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005;11:295-307.
3. James AH. Von Willebrand disease. Obstet Gynecol Surv 2006;61:136-145
4. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004;111:734-740
5. Dilley A, Drews C, Miller C, Lally C, Austin H, Ramaswamy D, et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 2001;97:630-636
6. Pruthi RK. A practical approach to genetic testing for von Willebrand disease. Mayo Clin Proc 2006;81:679-691
7. Valente MJ, Abramson N. Easy bruisability. South Med J 2006;99:366-370
8. Kirtava A, Crudder S, Dilley A, Lally C, Evatt B. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia 2004; 10:158-161
9. National Heart, Lung, and Blood Institute. The diagnosis, evaluation, and management of von Willebrand disease. NIH Publication No. 08-5832. Bethesda (MD): NHLBI; 2007. Available at: http://www.nhlbi.nih.gov/guidelines/vwd/ vwd.pdf. Retrieved August 14, 2009.
10. James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol 2009;201:12.e1-12.e8.
11. Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia 1999;5:313-317
12. The initial reproductive health visit. ACOG Committee Opinion No. 335. American College of Obstetricians and Gynecologists. Obstet Gynecol 2006;107:1215-1219
13. Philipp CS, Faiz A, Dowling N, Dilley A, Michaels LA, Ayers C, et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005;105:61-66
14. American College of Obstetricians and Gynecologists. Management of anovulatory bleeding. ACOG Practice Bulletin 14. Washington, DC: ACOG; 2000.
15. Lee CA. Women and inherited bleeding disorders: menstrual issues. Semin Hematol 1999;36:21-27
16. Philipp CS, Faiz A, Dowling NF, Beckman M, Owens S, Ayers C, et al. Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. Am J Obstet Gynecol 2008;198:163.e1-163.e8.
17. James AH, Manco-Johnson MJ, Yawn BP, Dietrich JE, Nichols WL. Von Willebrand disease: key points from the 2008 National Heart, Lung, and Blood Institute guidelines. Obstet Gynecol 2009;114:674-678
18. Kirtava A, Drews C, Lally C, Dilley A, Evatt B. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia 2003;9:292-297
19. Kouides PA. Current understanding of von Willebrand's disease in women-some answers, more questions. Haemophilia 2006;12(suppl 3):143-151
20. Jennings I, Kitchen S, Woods TA, Preston FE. Laboratory performance of haemophilia centres in developing countries: 3 years' experience of the World Federation of Hemophilia External Quality Assessment Scheme. Haemophilia 1998;4:739-746
21. Foster PA. The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995;74: 784-790
22. Miller CH, Dilley AB, Drews C, Richardson L, Evatt B. Changes in von Willebrand factor and factor VIII levels during the menstrual cycle. Thromb Haemost 2002;87: 1082-1083
23. Miller CH, Haff E, Platt SJ, Rawlins P, Drews CD, Dilley AB, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost 2003;1:2191-2197
24. Miller CH, Dilley A, Richardson L, Hooper WC, Evatt BL. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol 2001;67:125-129
25. Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D. Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 1999;93:4277-4283
26. Gralnick HR, McKeown LP, Wilson OM, Williams SB, Elin RJ. von Willebrand factor release induced by endotoxin. J Lab Clin Med 1989;113:118-122
27. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993;70:380-385
28. Ruggeri ZM, Ware J. von Willebrand factor. FASEB J 1993; 7:308-316
29. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 2007;5:1165-1169
30. Kingman CE, Kadir RA, Lee CA, Economides DL. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. BJOG 2004;111:1425-1428
31. Fraser IS, Porte RJ, Kouides PA, Lukes AS. A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding. Drug Saf 2008;31:275-282
32. Demers C, Derzko C, David M, Douglas J. Gynaecological and obstetric management of women with inherited bleeding disorders. Society of Obstetricians and Gynecologists of Canada. J Obstet Gynaecol Can 2005;27:707-732
33. National Hemophilia Foundation. von Willebrand disease. Available at: http://www.hemophilia.org/NHFWeb/MainPgs/ MainNHF.aspx?menuid=182&contentid= 47&rptname= bleeding. Retrieved August 14, 2009.